These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 705703)

  • 21. [Effect of oral hormonal contraceptives on hemostasis. 1. Plasma factors of coagulation].
    Barrantes A; Montero C; Cordero R
    Acta Med Costarric; 1980 Mar; 23(2):203-8. PubMed ID: 12338162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Action of hormonal contraceptives on the coagulation system and some of its inhibitors.
    Misz M; Beck P
    Acta Med Hung; 1986; 43(3):301-10. PubMed ID: 2438639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of ampicillin on oral contraceptive effectiveness.
    Friedman CI; Huneke AL; Kim MH; Powell J
    Obstet Gynecol; 1980 Jan; 55(1):33-7. PubMed ID: 7188714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of hyperestrogenism during in vitro fertilization on the fibrinolytic mechanism.
    Lox C; Cañez M; Prien S
    Int J Fertil Womens Med; 1998; 43(1):34-9. PubMed ID: 9580312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fasting serum growth hormone levels and growth hormone responses to exercise during normal menstrual cycles and cycles of oral contraceptives.
    Hansen AP; Weeke J
    Scand J Clin Lab Invest; 1974 Nov; 34(3):199-205. PubMed ID: 4428162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A lysine-absorbable plasminogen activator is elevated in conditions associated with increased fibrinolytic activity.
    Comp PC; Jacocks RM; Rubenstein C; Radcliffe R
    J Lab Clin Med; 1981 May; 97(5):637-45. PubMed ID: 6783711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of oral contraceptives and exercise on hemostatic and fibrinolytic mechanisms in trained women.
    Huisveld IA; Hospers JE; Bernink MJ; Erich WB; Bouma BN
    Int J Sports Med; 1983 May; 4(2):97-103. PubMed ID: 6874180
    [No Abstract]   [Full Text] [Related]  

  • 29. Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.
    Bonnar J; Daly L; Carroll E
    Int J Fertil; 1987; 32 Suppl():21-8. PubMed ID: 2906344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interrelationship between oral contraceptives and some parameters of the coagulative-fibrinolytic function (author's transl).
    Chieffi O; Brogioni M; Saltarelli O; Pecchioli S; Benardi M
    Patol Clin Ostet Ginecol; 1981; 9(2):164-72. PubMed ID: 12278647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of exercise and oral contraceptive agents on fibrinolytic potential in trained females.
    Huisveld IA; Kluft C; Hospers AJ; Bernink MJ; Erich WB; Bouma BN
    J Appl Physiol Respir Environ Exerc Physiol; 1984 Apr; 56(4):906-13. PubMed ID: 6725068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
    Ferreira AC; Montes MB; Franceschini SA; Toloi MR
    Int J Fertil Womens Med; 2001; 46(5):265-70. PubMed ID: 11720199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proceedings: Hemophilia: modified by a post-exercise plasminogen activator.
    Hampton JW; Weidenbach A; Skye GE; Rubenstein C; Taylor FB
    Thromb Diath Haemorrh; 1975 Nov; 34(2):612. PubMed ID: 810
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral contraceptives and fibrinolysis among female cyclists before and after exercise.
    Huisveld IA; Hospers AJ; Bernink MJ; Biersteker MW; Erich WB; Bouma BN
    J Appl Physiol Respir Environ Exerc Physiol; 1982 Aug; 53(2):330-4. PubMed ID: 7118654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of oral contraceptive on blood coagulation and blood fibrinolysis.
    Sharma V
    J Obstet Gynaecol India; 1977 Aug; 27(4):567-75. PubMed ID: 590595
    [No Abstract]   [Full Text] [Related]  

  • 38. Some observations on the release of extrinsic and intrinsic plasminogen activators during exercise in man.
    Marsh N; Gaffney P
    Haemostasis; 1980; 9(4):238-47. PubMed ID: 7190533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Plasminogen activators in assessing the reaction of patients with chronic obstructive bronchitis to physical loading].
    Dovgan' AA
    Lik Sprava; 1992 Aug; (8):39-41. PubMed ID: 1475923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced plasminogen activator content of the endometrium in oral contraceptive users.
    Casslén B; Astedt B
    Contraception; 1983 Aug; 28(2):181-8. PubMed ID: 6685602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.